News for Healthier Living

Roswell Park Launches Exclusive CD83 CAR T-Cell Clinical Trial for Patients with Relapsed or Refractory AML

Research shows this therapy targeting the CD83 antigen on leukemia cells holds promise for treating acute myeloid leukemia

April 14, 2026


April 15 2026

April 14 2026

April 13 2026

April 12 2026

April 11 2026

April 10 2026

April 9 2026

April 8 2026

April 7 2026

April 6 2026

April 5 2026

April 4 2026

April 3 2026

April 2 2026

April 1 2026